Therefore, genotyping data from XRCC1 and XRCC3 genes, incorporating the haplotype and synergism analytical strategies would facilitate the identification of individuals at high risk of developing lung cancer in future clinical screening. Here, XRCC1 is linked to lung carcinoma.